Neuraminidase inhibitors for influenza

BMJ. 2014 Apr 9:348:g2548. doi: 10.1136/bmj.g2548.

Author

Harlan M Krumholz¹

Affiliation

¹ Department of Internal Medicine, Yale University School of Medicine New Haven, CT 06510, USA; Department of Health Policy and Management, Yale School of Public Health; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital.

PMID: 24811413
DOI: 10.1136/bmj.g2548

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Antiviral Agents / therapeutic use*
Enzyme Inhibitors / therapeutic use*
Humans
Influenza, Human / drug therapy*
Neuraminidase / antagonists & inhibitors*
Oseltamivir / therapeutic use*
Risk Assessment
Zanamivir / therapeutic use*

Substances

Antiviral Agents
Enzyme Inhibitors
Oseltamivir
Neuraminidase
Zanamivir

Grants and funding